Results of 2022 Annual Shareholder Meeting

5 August 2022 Results of 2022 Annual Shareholder Meeting At AFT Pharmaceuticals Limited's (NZX: AFT / ASX: AFP) annual shareholder meeting held at the Milford Cruising Club, 24 Craig Road, Milford, Auckland, New Zealand today, shareholders were asked to vote on two resolutions, both of which were supported by the Board. As required by NZX Listing Rule 6.1, all voting was conducted by a poll. The resolutions passed by shareholders were: 1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2023 financial year. 2. That Dr Hartley Atkinson be re-elected as a director of AFT Pharmaceuticals Limited. 3. That Mr Jon Lamb be elected as a director of AFT Pharmaceuticals Limited. Detail of the total number of votes cast in person or by a proxy holder are: Resolution For Against Abstain 1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2023 financial year. 84,623,761 99.99% 11,972 0.01% - 2. That Dr Hartley Atkinson be re-elected as a director of AFT Pharmaceuticals Limited. 84,635,273 100.00% - - 460 3. That Mr Jon Lamb be elected as a director of AFT Pharmaceuticals Limited. 84,630,161 99.99% 5,112 0.01% 460 Authority for this announcement Name of person authorised to make this announcement Malcolm Tubby, Chief Financial Officer Contact person for this announcement Malcolm Tubby Contact phone number +64 9 488 0232 Contact email address Investor.relations@aftpharm.com Date of release through MAP 5 August 2022 End CA:00396479 For:AFT Type:MEETING Time:2022-08-05 13:12:34